Skip to content
Screener

Axcelis Technologies ACLS Business Segments — Nonoperating Income Expense

Similar metrics at other companies

Alumis Inc. logo
ALMSSingle Reportable — Nonoperating Income Expense
$5.36M+109%
Capricor Therapeutics logo
CAPRSingle Reportable — Nonoperating Income Expense
$2.83M+379%
LQD
LQDASingle Reportable — Nonoperating Income Expense
-$4.72M-60.5%
Merit Medical Systems logo
MMSISingle Reportable — Nonoperating Income Expense
$9.39M+405%
Pulse Biosciences, Inc. logo
PLSESingle Reportable — Nonoperating Income Expense
-$615K+44.4%
Aclaris Therapeutics logo
ACRSSingle Reportable — Nonoperating Income Expense
$2.73M-8.3%

Other financials

Income statement

See full
Revenue$215.2M+10.6%
Gross profit$91.2M+4.4%
Operating income$20.3M-30.0%
Net income$23.3M-25.8%
EPS (diluted)$0.75-23.5%

Balance sheet

See full
Cash & equivalents$155.0M-10.7%
Total debt$71.5M-2.5%
Total equity$1.1B+4.2%
Total assets$1.4B+4.8%

Cash flow

See full
Operating cash flow$18.4M-53.8%
CapEx$3.6M+79.0%
Free cash flow$14.8M-60.7%

Valuation

See full
Market cap$4.2B+76.5%
Enterprise value$4.12B+80.7%
P/E45.3×+30.3×
P/S4.9×+2.2×

Profitability

See full
Gross margin43%-1.9pp
Operating margin10.3%-7.5pp
Net margin10.7%-7.0pp
FCF margin8.6%-5.1pp

Returns & leverage

See full
Return on equity8.9%-7.3pp
Debt / equity0.1×0.0×
Current ratio4.9×-1.1×

Where this comes from

Reported directly by Axcelis Technologies in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The source filing: Axcelis Technologies’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:10 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-091999
Line itemThree months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Research and development28,97727,06457,49354,192
Sales and marketing19,55415,00336,90830,127
General and administrative22,37716,31149,13833,668
Total other income5,0676,0327,7429,957
Income tax provision2,0573,6213,4688,126
Segment Net Income23,29131,37632,50559,955
Reconciliation of profit or loss Adjustments and reconciling items----
Net income$23,291$31,376$32,505$59,955

Item 1. Financial Statements (Unaudited)

FAQ

What is Axcelis Technologies's business segments — nonoperating income expense?
Axcelis Technologies (ACLS) reported business segments — nonoperating income expense of $5.07M in Q2 2026.
How has Axcelis Technologies's business segments — nonoperating income expense changed year-over-year?
Axcelis Technologies's business segments — nonoperating income expense decreased by 16.0% year-over-year, from $6.03M to $5.07M.
What is the long-term trend for Axcelis Technologies's business segments — nonoperating income expense?
Over 3 years (2022 to 2025), Axcelis Technologies's business segments — nonoperating income expense has grown at a 36.3% compound annual growth rate (CAGR), from -$7.48M to $18.93M.
What does business segments — nonoperating income expense mean?
This metric accounts for financial activities outside of core operations, such as interest income, interest expense, and foreign currency exchange gains or losses. It helps investors isolate the impact of financing decisions and external market factors from the company's primary operational performance.

Ask your AI about Axcelis Technologies's business segments — nonoperating income expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude